Merck

YTD

ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

CEO

Robert M. Davis

CEORobert M. Davis

Employees

75,000

Employees75,000

Headquarters

Rahway, New Jersey

HeadquartersRahway, New Jersey

Founded

1891

Founded1891

Employees

75,000

Employees75,000

MRK Key Statistics

Market cap

200.83B

Market cap200.83B

Price-Earnings ratio

11.87

Price-Earnings ratio11.87

Dividend yield

3.93%

Dividend yield3.93%

Average volume

12.08M

Average volume12.08M

High today

$81.92

High today$81.92

Low today

$79.86

Low today$79.86

Open price

$81.70

Open price$81.70

Volume

11.82M

Volume11.82M

52 Week high

$128.73

52 Week high$128.73

52 Week low

$73.31

52 Week low$73.31

MRK News

Seeking Alpha 12h

Bristol Myers fails in late-stage trial for Merck-partnered anemia therapy in blood cancer

Bristol Myers Squibb (NYSE:BMY) announced on Friday that its anemia therapy, Reblozyl, developed with Merck (NYSE:MRK), did not meet the main goal in a Phase 3...

Simply Wall St 4d

Merck Partners With Gates Foundation For HIV PrEP Trials In 16 Countries

recently announced the initiation of its Phase 3 EXPrESSIVE clinical trials for MK-8527, a new HIV prevention drug, reflecting its commitment to addressing glob...

Analyst ratings

64%

of 25 ratings

Buy

64%

Hold

36%

Sell

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.